Director/PDMR Shareholding

Optima Health PLC

28 April 2026

 

28 April 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Director / PDMR Dealings

Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces that following Admission of the Open Offer shares on 23 April 2026, the Directors / PDMRs, Julie Robertson, Jonathan Thomas, Heidi Giles, Simon Arnold, Adam Councell and Joanne Newey have subscribed for an aggregate of 51,560 Open Offer Shares, representing approximately 0.05% of the Company's enlarged issued share capital.

Details of the Ordinary Shares held by each of the Directors/PDMRs are detailed below:

Director/PDMR	Current shareholding	% of issued share capital	Shareholding immediately following Admission	% of the enlarged issued share capital following Admission
Julia Robertson	21,500 Ordinary Shares	0.02	26,343	0.02
Jonathan Thomas	218,356 Ordinary Shares	0.25	229,856	0.21
Heidi Giles	83,228 Ordinary Shares	0.09	92,000	0.08
Simon Arnold	20,451 Ordinary Shares	0.02	32,100	0.03
Adam Councell	34,608 Ordinary Shares	0.04	42,404	0.04
Joanne Newey	84,080 Ordinary Shares	0.09	91,080	0.08

Capitalised terms used but not defined in this announcement shall have the meaning ascribed to such terms in the Circular unless the context requires otherwise.

Optima Health Jonathan Thomas, CEO Heidi Giles, CFO [phone] [e-mail] Nominated Adviser and Joint Corporate Broker Panmure Liberum Limited Emma Earl / Will Goode/ Mark Rogers Rupert Dearden Debt Advisory (sole debt adviser on the transaction): Dan Howlett / Ben Handler [phone] Joint Corporate Broker Cavendish Capital Markets Geoff Nash / Ben Jeynes / George Lawson Julian Morse / Michael Johnson/ Nigel Birks + 44 (0)20 7220 0500 UK Financial PR Adviser ICR Healthcare Mary-Jane Elliott / Angela Gray / Lindsey Neville [e-mail]

About Optima

Optima is the UK's leading provider of occupational health and wellbeing services, directly influencing and improving people's lives for 25 years. Optima's incredible team of professionals quickly and effectively encapsulate client's needs, supporting organisations of all shapes and sizes. Through tailored solutions and innovative systems, Optima offers unparalleled clinical expertise to its clients. These solutions ensure that processes are simple and allow its clients to spend more time focusing on their employees driving a healthy, high-performing workplace. For more information visit www.optima health.co.uk.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	1.     Julia Robertson 2.     Jonathan Thomas 3.     Heidi Giles 4.     Simon Arnold 5.     Adam Councell 6.     Joanne Newey
2	Reason for the notification
a)	Position/status	1.     Non-Executive Chairman 2.     Chief Executive Officer 3.     Chief Financial Officer 4.     Non-Executive Director 5.     Non-Executive Director 6.     Chief Commercial Officer (PDMR)
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Optima Health plc
b)	LEI	213800TOPWJSRCW4ON08
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	GB00BRSCY602
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Purchase Price	Volume
			175 pence per Ordinary Share	1.     4,843 2.     11,500 3.     8,772 4.     11,649 5.     7,796 6.     7,000
d)	Aggregated information
	- Aggregated volume	51,560 shares
		175.00 pence
	- Price
e)	Date of the transaction	23 April 2026
f)	Place of the transaction	London Stock Exchange, AIM Market

 

END